Abstract:Stroke is the major cause of death and disability worldwide, and the thrombolytic therapy currently available was unsatisfactory. 14-3-3 epsilon is a well characterized member of 14-3-3 family, and has been reported to protect neurons against apoptosis in cerebral ischemia. However, it cannot transverse blood brain barrier (BBB) due to its large size. A protein transduction domain (PTD) of HIV TAT protein, is capable of delivering a large variety of proteins into the brain. In this study, we generated a fusion protein TAT-14-3-3 epsilon, and evaluated its potential neuroprotective effect in rat focal ischemia/reperfusion (I/R) model. Western blot analysis validated the efficient transduction of TAT-14-3-3 epsilon fusion protein into brain via a route of intravenous injection. TAT-14-3-3 epsilon pre-treatment 2 h before ischemia significantly reduced cerebral infarction volume and improved neurologic score, while post-treatment 2 h after ischemia was less effective. Importantly, pre- or post-ischemic treatment with TAT-14-3-3 epsilon significantly increased the number of surviving neurons as determined by Nissl staining, and attenuated I/R-induced neuronal apoptosis as showed by the decrease in apoptotic cell numbers and the inhibition of caspase-3 activity. Moreover, the introduction of 14-3-3 epsilon into brain by TAT-mediated delivering reduced the formation of autophagosome, attenuated LC3B-II upregulation and reversed p62 downregulation induced by ischemic injury. Such inhibition of autophagy was reversed by treatment with an autophagy inducer rapamycin (RAP), which also attenuated the neuroprotective effect of TAT-14-3-3 epsilon. Conversely, autophagy inhibitor 3-methyladenine (3-MA) inhibited I/R-induced the increase in autophagic activity, and attenuated I/R-induced brain infarct. These results suggest that TAT-14-3-3 epsilon can be efficiently transduced into brain and exert significantly protective effect against brain ischemic injury through inhibiting neuronal apoptosis and autophagic activation.

Biosynthesis and Biological Evaluation of a Neotype Neurotrophin TAT-BDNF

TAT-Mediated Protein Transduction of Nogo Extracellular Peptide 1-40 and Its Biological Activity

Bcl-2 Gene Therapy for Apoptosis Following Traumatic Brain Injury.

Functional recovery after transplantation of neural stem cells modified by brain-derived neurotrophic factor in rats with cerebral ischaemia

Brain-derived Neurotrophic Factor Combined with Neural Stem Cells Transplantation in Treatment of Severe Traumatic Brain Injury in Rats

Cloning Rat BDNF Gene and Construction of a Recombinant Retroviral Vector Plxsn-Bdnf

Neuroprotective Effect of TAT-14-3-3ε Fusion Protein against Cerebral Ischemia/Reperfusion Injury in Rats

Design, Preparation and Activity Evaluation of Two Novel Proteins with Thrombolysis Or/and Neuroprotection

Neuroprotective Effect Of Tat-14-3-3 Epsilon Fusion Protein Against Cerebral Ischemia/Reperfusion Injury In Rats

Targeted Delivery of Neurogenin-2 Protein in the Treatment for Cerebral Ischemia-Reperfusion Injury.

EXPRESSING HUMAN MATURED BRAIN-DERIVED NEUROTROPHIC FACTOR GENE IN E.Coli AND DETERMINING ITS BIOACTIVITY

Targeted delivery of polypeptide nanoparticle for treatment of traumatic brain injury

Construction, Identification and Application of Fusion Plasmid of Brain-Derived Neurotrophic Factor-Green Fluorescent Protein

Neuroprotection by cell permeable TAT-mGluR1 peptide in ischemia: synergy between carrier and cargo sequences.

TAT-mediated Delivery of Neuroglobin Protects Against Focal Cerebral Ischemia in Mice

Tetramethylpyrazine nitrone activates the BDNF/Akt/CREB pathway to promote post-ischaemic neuroregeneration and recovery of neurological functions in rats.

Expression, Purification and Bio-activity Analysis of Recombined Human HBNF

Protein Transduction Technique and Its Application in Neuroprotection

Therapeutic Potential of a TrkB Agonistic Antibody for Ischemic Brain Injury

Multiple Functions of Precursor BDNF to CNS Neurons: Negative Regulation of Neurite Growth, Spine Formation and Cell Survival

A Novel NGF Receptor Agonist B355252 Ameliorates Neuronal Loss and Inflammatory Responses in a Rat Model of Cerebral Ischemia